About Profound Medical
Profound Medical Inc. markets the TULSA-PRO transurethral ultrasound ablation system for non-invasive, MRI-guided ablation of the prostate gland to treat localized prostate cancer.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Profound Medical. Response typically within 48 hours.
Company Info
TypePublic
StockPRN (NASDAQ)
Founded2012
Employees165
Revenue$24M
HQMississauga, Canada
